Update on 28-31 August 2013 EACPT Congress in Geneva

-->

The abstract deadline for the next biennial EACPT Congress is only 6 weeks away: 8th April 2013.
See the EACPT Congress blog for summaries on many of the symposia to be held during the Congress: from new therapeutic biomarkers, to new biomarker and treatment targets (cancer, eye disease, predictive pharmacogenetics, inborn errors of metabolism, therapeutic drug monitoring ...), and how to improve safety in prescribing ...

The Congress will be held at the International Congress Centre of Geneva from 28 to 31 August 2013. 

-->
Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

Abstract submission

Registration

2013 EACPT Geneva Congress website.

Update from Geneva

The latest meeting of the EACPT Executive has just finished in Geneva in advance of the next major EACPT biennial congress, which is to be held in this lakeside Swiss city in the summer of 2013.

Here are three important updates about the EACPT's scientific and educational programmes:

The next EACPT summer school will be held on 23rd to 25th August 2012 in Amsterdam, with an excellent range of topics for delegates interested in education in key principles relevant to clinical pharmacology. See the website for further information.

At the next European Pharmacology Congress in Granada  July 17th - 20th, 2012,  EACPT Vice-President Professor Tabassome Simon from Paris will give the keynote EACPT lecture on the application of pharmacogenetic testing to cardiovascular therapeutics.

Cathedral and Lake Geneva fountain (jet d'eau)

The EACPT is developing the programme for its next biennial congress, to be held in beautiful Geneva, 28th - 31st August in 2013. Key themes at the congress will range from bedside pharmacology for special patient groups to pharmacology & toxicology, and pharmacology and society. Specific topics will include advances in personalised diagnostics to improve the safety and effectiveness of medicines, updates on new biological approaches to ocular disease, therapeutics of cardiovascular, cancer and inflammatory disease, clinical trial design and regulation, and drug safety and toxicology.